Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$537M |
| 2 |
Goldman Sachs
GS
|
+$200M |
| 3 |
Intuit
INTU
|
+$149M |
| 4 |
ExxonMobil
XOM
|
+$149M |
| 5 |
Salesforce
CRM
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$172M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$169M |
| 3 |
Amazon
AMZN
|
+$158M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$155M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.54% |
| 2 | Financials | 12.61% |
| 3 | Industrials | 10.64% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Healthcare | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
PUT
VanEck Gold Miners ETF
GDX
$32.8B
| $1.17M | ﹤0.01% |
+39,800
| New | +$1.3M |
|
|
ABB
1277
DELISTED
ABB Ltd
ABB
| $1.17M | ﹤0.01% |
35,009
+4,519
| +15% | +$164K |
|
1278
Vir Biotechnology
VIR
$1.81B
| $1.17M | ﹤0.01% |
26,811
+7,468
| +39% | +$323K |
|
|
LMACU
1279
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
| $1.17M | ﹤0.01% |
112,956
-21,433
| -16% | -$225K |
|
1280
Karyopharm Therapeutics
KPTI
$43.5M
| $1.17M | ﹤0.01% |
13,361
+10,051
| +304% | +$1.04M |
|
1281
Rapid Micro Biosystems
RPID
$83.3M
| $1.16M | ﹤0.01% |
+62,841
| New | +$1.3M |
|
1282
CALL
Amcor
AMCR
$21.9B
| $1.16M | ﹤0.01% |
+20,000
| New | +$1.19M |
|
|
IPHA
1283
Innate Pharma
IPHA
$254M
| $1.16M | ﹤0.01% |
+187,484
| New | +$808K |
|
|
PFSW
1284
DELISTED
PFSweb, Inc.
PFSW
| $1.16M | ﹤0.01% |
+89,629
| New | +$1.12M |
|
1285
CALL
Adobe
ADBE
$109B
| $1.15M | ﹤0.01% |
2,000
+1,000
| +100% | +$629K |
|
|
BWIN
1286
Baldwin Insurance Group
BWIN
$2.99B
| $1.14M | ﹤0.01% |
+34,148
| New | +$1.07M |
|
1287
CenterPoint Energy
CNP
$25.6B
| $1.13M | ﹤0.01% |
+45,778
| New | +$1.17M |
|
1288
Procept Biorobotics
PRCT
$1.24B
| $1.12M | ﹤0.01% |
+29,355
| New | +$1.13M |
|
|
BRSL
1289
CALL
Brightstar Lottery PLC
BRSL
$2.12B
| $1.12M | ﹤0.01% |
+42,500
| New | +$901K |
|
1290
AMC Global Media
AMCX
$530M
| $1.11M | ﹤0.01% |
23,880
+2,042
| +9% | +$104K |
|
1291
Canadian Natural Resources
CNQ
$102B
| $1.11M | ﹤0.01% |
61,760
-22,109
| -26% | -$364K |
|
1292
Ormat Technologies
ORA
$6.53B
| $1.11M | ﹤0.01% |
+16,611
| New | +$1.15M |
|
1293
CALL
ARK Innovation ETF
ARKK
$6.6B
| $1.1M | ﹤0.01% |
10,000
-50,000
| -83% | -$6.02M |
|
1294
CALL
FedEx
FDX
$79B
| $1.1M | ﹤0.01% |
+5,000
| New | +$1.36M |
|
1295
CALL
Teradyne
TER
$57.3B
| $1.09M | ﹤0.01% |
10,000
+2,500
| +33% | +$304K |
|
1296
Simmons First National
SFNC
$3.28B
| $1.09M | ﹤0.01% |
36,832
-74,675
| -67% | -$2.11M |
|
1297
NovoCure
NVCR
$2.05B
| $1.09M | ﹤0.01% |
+9,352
| New | +$1.41M |
|
|
PROCW
1298
DELISTED
Procaps Group, S.A. Warrants
PROCW
| $1.08M | ﹤0.01% |
+1,000,000
| New | +$1.08M |
|
|
TSP
1299
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $1.08M | ﹤0.01% |
29,099
+18,799
| +183% | +$792K |
|
1300
Palantir
PLTR
$415B
| $1.07M | ﹤0.01% |
44,537
-117,131
| -72% | -$2.86M |
|
Similar funds
Dmitry Balyasny's Q3 2021 Portfolio in Review
As of Q3 2021, Dmitry Balyasny held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.
- Dmitry Balyasny's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
- Dmitry Balyasny's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
- Dmitry Balyasny fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
- Dmitry Balyasny opened 770 new positions and closed 817 in Q3 2021.
- Dmitry Balyasny's portfolio value rose 14% quarter-over-quarter to $24B.
Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.